Total intravenous or inhalational volatile anaesthesia and survival after colorectal cancer surgery: a Swedish national registry study
Anaesthesia · 2025
DOI: 10.1111/anae.16495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anaesthesia, 2025. Verfasst von Anna Enlund und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia and Intensive Care, Vastmanland Hospital, Vasteras, Sweden. Hauptthemen laut MEDLINE: Anesthetics, Inhalation, Colorectal Neoplasms, Anesthesia, Inhalation, Anesthesia, Intravenous. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Retrospective studies suggest that inhalational volatile anaesthetic agents may contribute to an increased risk of metastasis and reduction in survival rates when used during cancer surgery. This relationship may vary between cancer types due to different tumour biology and differences in surgical procedures. This study aimed to investigate the relationship between the type of anaesthetic used for maintenance of anaesthesia (propofol or inhalational volatile anaesthetic agent) and survival in patients with stage 1–3 colorectal cancer who underwent resection surgery under general anaesthesia in Sweden between 2014 and 2019.
Methods
We identified patients from the Swedish Colorectal Cancer Registry. Their data, including cancer characteristics and adjuvant treatment, were then merged with information from the Swedish Peri‐operative Registry. The primary outcome was overall survival, with disease‐free survival as a secondary outcome.
Results
Of the 11,598 patients included, 8161 had colon cancer and 3437 had rectal cancer. General anaesthesia was maintained with propofol in 2346 (20%) patients, while 9252 (80%) received an inhalational volatile anaesthetic agent. In the unmatched cohort, patients who had general anaesthesia maintained with propofol for colon cancer surgery showed improved survival compared with those receiving an inhalational volatile anaesthetic agent (hazard ratio 0.83, 95%CI 0.72–0.95, p = 0.008). After 1:2 propensity score matching, we observed no significant difference in survival rates in this group (hazard ratio 0.89, 95%CI 0.76–1.04, p = 0.127). In the rectal cancer group, there was no difference in survival in either the unmatched cohort (hazard ratio 0.83, 95%CI 0.65–1.08, p = 0.166) or after propensity score matching (hazard ratio 0.95, 95%CI 0.71–1.25, p = 0.702). There was no significant difference in disease‐free survival in either type of cancer.
Discussion
We found no association between the choice of agent for maintenance of anaesthesia and long‐term survival outcomes in patients with colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesia and Intensive Care, Vastmanland Hospital, Vasteras, Sweden.
- Centre for Clinical Research, Uppsala University, Vastmanland Hospital, Vasteras, Sweden.
- Department of Surgery, Vastmanland Hospital, Vasteras, Sweden.
- Epistat AB, Uppsala, Sweden.
- Department of Surgical Sciences, Anaesthesiology and Intensive Care, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Mats Enlund
Zitieren
APA
Enlund, A., Nikberg, M., Berglund, A., Östberg, E., & Enlund, M. (2025). Total intravenous or inhalational volatile anaesthesia and survival after colorectal cancer surgery: a Swedish national registry study. Anaesthesia. https://doi.org/10.1111/anae.16495
Vancouver
Enlund A, Nikberg M, Berglund A, Östberg E, Enlund M. Total intravenous or inhalational volatile anaesthesia and survival after colorectal cancer surgery: a Swedish national registry study. Anaesthesia. 2025. doi:10.1111/anae.16495
BibTeX
@article{Enlund2025,
author = {Enlund, Anna and Nikberg, Maziar and Berglund, Anders and Östberg, Erland and Enlund, Mats},
title = {Total intravenous or inhalational volatile anaesthesia and survival after colorectal cancer surgery: a Swedish national registry study},
journal = {Anaesthesia},
year = {2025},
doi = {10.1111/anae.16495}
}
EUVIMED